Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 5
Submit an article Journal homepage
225
Views
3
CrossRef citations to date
0
Altmetric
Original research

Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model

Jéssica Barreto Ribeiro Dos Santosa Health Assessment, Technology, and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil;b Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilCorrespondence[email protected]
View further author information
,
Michael Ruberson Ribeiro da Silvaa Health Assessment, Technology, and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil;b Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilORCID Iconhttps://orcid.org/0000-0003-2550-7249View further author information
ORCID Icon,
Alessandra Maciel Almeidab Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;c Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Minas Gerais, BrasilView further author information
,
Francisco De Assis Acurciob Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;d Department of Social and Preventive Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilORCID Iconhttps://orcid.org/0000-0002-5880-5261View further author information
ORCID Icon &
Juliana Alvares-Teodorob Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, BrazilORCID Iconhttps://orcid.org/0000-0002-0210-0721View further author information
ORCID Icon
Pages 1011-1016 | Received 16 Jul 2020, Accepted 20 Oct 2020, Published online: 02 Nov 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Qian Ding, Dane Shiltz, Dana Hossami & Alison M Konieczny. (2022) The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States. Expert Review of Pharmacoeconomics & Outcomes Research 22:8, pages 1231-1241.
Read now
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Alessandra Maciel Almeida, Juliana Alvares-Teodoro & Francisco De Assis Acurcio. (2022) Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model. Expert Review of Pharmacoeconomics & Outcomes Research 22:3, pages 473-479.
Read now

Articles from other publishers (1)

Ahmad Gholami, Jassem Azizpoor, Elham Aflaki, Mehdi Rezaee & Khosro Keshavarz. (2021) Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept. BioMed Research International 2021, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.